Stay updated with breaking news from Vijay Modur. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Eloxx Pharmaceuticals, Inc. (NASDAQ: ELOX) shares are rocketing higher on Tuesday after Oppenheimer raised its price target from $50 to $55.
Shares of Eloxx Pharmaceuticals, Inc. (ELOX) are surging over 110% on Tuesday morning after its price target was raised by analysts at Oppenheimer Holdings Inc. from $50.
Publication titled “A Novel Class of Ribosome Modulating Agents Exploits Cancer Ribosome Heterogeneity to Selectively Target the CMS2 Subtype of Colorectal…